{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:48Z","timestamp":1790742048805,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","award":["4709553"],"award-info":[{"award-number":["4709553"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007798","name":"University of Helsinki Research Foundation","doi-asserted-by":"publisher","award":["TYH2022315"],"award-info":[{"award-number":["TYH2022315"]}],"id":[{"id":"10.13039\/100007798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007798","name":"University of Helsinki Research Foundation","doi-asserted-by":"publisher","award":["Y780023006"],"award-info":[{"award-number":["Y780023006"]}],"id":[{"id":"10.13039\/100007798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.preghy.2025.101212","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:12:31Z","timestamp":1745939551000},"page":"101212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pregnancy-related Thrombotic Microangiopathy has a spectrum of underlying causes"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0501-7934","authenticated-orcid":false,"given":"Sivan","family":"Livson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9833-3588","authenticated-orcid":false,"given":"Jenni","family":"Heikkinen-Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Inkeri","family":"Lokki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-501X","authenticated-orcid":false,"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2025.101212_b0005","article-title":"Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery","volume":"11","author":"Livson","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.preghy.2025.101212_b0010","doi-asserted-by":"crossref","unstructured":"Livson S VS, Lokki A.I, Holster T, Rahkonen L, Kalliala I, Nieminen P, Salonen A, Meri S. Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition. Frontiers in Immunology. 2022(13:925630).","DOI":"10.3389\/fimmu.2022.925630"},{"issue":"1","key":"10.1016\/j.preghy.2025.101212_b0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal","year":"2015","journal-title":"Mol. Immunol."},{"issue":"19","key":"10.1016\/j.preghy.2025.101212_b0020","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.preghy.2025.101212_b0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.humimm.2021.03.006","article-title":"Pregnancy induced TMA in severe preeclampsia results from complement-mediated thromboinflammation","volume":"82","author":"Lokki","year":"2021","journal-title":"Hum Immunol."},{"key":"10.1016\/j.preghy.2025.101212_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/20543581231209009","article-title":"Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report","volume":"10","author":"Bruno","year":"2023","journal-title":"Can J Kidney Health Dis."},{"issue":"3","key":"10.1016\/j.preghy.2025.101212_b0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ijgo.14918","article-title":"Long-term survival and renal outcomes of thrombotic microangiopathy in pregnancy: A retrospective cohort study","volume":"163","author":"Chen","year":"2023","journal-title":"Int J Gynaecol Obstet."},{"issue":"2","key":"10.1016\/j.preghy.2025.101212_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100084","article-title":"Etiology and outcomes: Thrombotic microangiopathies in pregnancy","volume":"7","author":"Scully","year":"2023","journal-title":"Res Pract Thromb Haemost."},{"issue":"4","key":"10.1016\/j.preghy.2025.101212_b0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"issue":"15","key":"10.1016\/j.preghy.2025.101212_b0050","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/1873-3468.12284","article-title":"Self-nonself discrimination by the complement system","volume":"590","author":"Meri","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.preghy.2025.101212_b0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.13156","article-title":"Alternative pathway diagnostics","volume":"313","author":"Thurman","year":"2023","journal-title":"Immunol Rev."},{"issue":"4","key":"10.1016\/j.preghy.2025.101212_b0060","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0040-1702225","article-title":"Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy","volume":"120","author":"Gavriilaki","year":"2020","journal-title":"Thrombosis and Antibody Haemostasis."},{"issue":"1","key":"10.1016\/j.preghy.2025.101212_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imr.13131","article-title":"Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases","volume":"313","author":"Rodriguez de Cordoba","year":"2023","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.preghy.2025.101212_b0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.preghy.2025.101212_b0075","series-title":"BJOG : an International Journal of Obstetrics and Gynaecology","article-title":"Identification of complement factor H variants that predispose to pre-eclampsia: A genetic and functional study","author":"Lokki","year":"2023"},{"key":"10.1016\/j.preghy.2025.101212_b0080","article-title":"A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?","volume":"1","author":"Griffin","year":"2020","journal-title":"Ther Adv Rare Dis."},{"issue":"4","key":"10.1016\/j.preghy.2025.101212_b0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.preghy.2025.101212_b0090","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/bjh.16977","article-title":"Caplacizumab treatment for acquired refractory thrombotic thrombocytopenic purpura","volume":"191","author":"Khan","year":"2020","journal-title":"Br J Haematol."},{"issue":"3","key":"10.1016\/j.preghy.2025.101212_b0095","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1097\/MPH.0000000000002843","article-title":"Successful Treatment of Acquired Thrombotic Thrombocytopenic Purpura With Caplacizumab Combined With Plasma Exchanges and Immune Suppression in 3 Children","volume":"46","author":"Kalinina","year":"2024","journal-title":"J Pediatr Hematol Oncol."},{"issue":"3","key":"10.1016\/j.preghy.2025.101212_b0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/tme.12615","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial)","volume":"29","author":"Estcourt","year":"2019","journal-title":"Transfus Med."},{"key":"10.1016\/j.preghy.2025.101212_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697313","article-title":"Expanding Horizons in Complement Analysis and Quality Control","volume":"12","author":"Frazer-Abel","year":"2021","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101212_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jth.13174","article-title":"Subcommittees on Women' s Health Issues in T, Haemostasis, on Disseminated Intravascular C. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH","volume":"14","author":"Collins","year":"2016","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.preghy.2025.101212_b0115","doi-asserted-by":"crossref","unstructured":"International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care. 2010;33(3):676-82.","DOI":"10.2337\/dc09-1848"},{"key":"10.1016\/j.preghy.2025.101212_b0120","article-title":"National Institute of Finland for Health and Welfare","author":"Vuori","year":"2018","journal-title":"Perinatal Statistics: Parturients, Deliveries and Newborns."},{"issue":"1","key":"10.1016\/j.preghy.2025.101212_b0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Open-Label Trial. Am J Kidney Dis."},{"issue":"19","key":"10.1016\/j.preghy.2025.101212_b0130","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"10.1016\/j.preghy.2025.101212_b0135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ekir.2020.10.036","article-title":"Diagnostic Dilemma of Thrombotic Microangiopathy in Pregnancy","volume":"6","author":"Kaartinen","year":"2021","journal-title":"Kidney Int Rep."},{"issue":"1","key":"10.1016\/j.preghy.2025.101212_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)02734-6","article-title":"Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis","volume":"73","author":"Cerneca","year":"1997","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"4","key":"10.1016\/j.preghy.2025.101212_b0145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/eurpub\/ckab078","article-title":"Gestational diabetes among women of migrant origin in Finland-a population-based study","volume":"31","author":"Bastola","year":"2021","journal-title":"Eur J Public Health."},{"key":"10.1016\/j.preghy.2025.101212_b0150","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice C. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2024. Diabetes care. 2024;47(Suppl 1):S282-S94.","DOI":"10.2337\/dc24-S015"},{"issue":"17","key":"10.1016\/j.preghy.2025.101212_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175502","article-title":"Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus","volume":"27","author":"Bernea","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.preghy.2025.101212_b0160","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1186\/s12884-021-04031-w","article-title":"The role of complement factor H in gestational diabetes mellitus and pregnancy","volume":"21","author":"Li","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"10.1016\/j.preghy.2025.101212_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152707","article-title":"Complement and coagulation crosstalk - Factor H in the spotlight","volume":"228","author":"Heurich","year":"2023","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.preghy.2025.101212_b0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.preghy.2025.101212_b0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/16078454.2020.1731969","article-title":"A novel compound heterozygous mutation in DGKE in a Chinese patient causes atypical hemolytic uremic syndrome","volume":"25","author":"Li","year":"2020","journal-title":"Hematology"},{"issue":"11","key":"10.1016\/j.preghy.2025.101212_b0180","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.ekir.2022.08.032","article-title":"Mismatches in Gene Deletions and Kidney-related Proteins as Candidates for Histocompatibility Factors in Kidney Transplantation","volume":"7","author":"Markkinen","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"3","key":"10.1016\/j.preghy.2025.101212_b0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/humu.9408","article-title":"De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome","volume":"27","author":"Heinen","year":"2006","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.preghy.2025.101212_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060352","article-title":"Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32","volume":"8","author":"Holmes","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.preghy.2025.101212_b0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/nep.14004","article-title":"High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome","volume":"27","author":"Kandari","year":"2022","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.preghy.2025.101212_b0200","article-title":"Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease","volume":"16","author":"Heparin","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.preghy.2025.101212_b0205","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5292","article-title":"Predictive value of the sFlt\u20111\/PlGF ratio in women with suspected preeclampsia: An update (Review)","volume":"52","author":"Velegrakis","year":"2023","journal-title":"Int J Mol Med."},{"issue":"3","key":"10.1016\/j.preghy.2025.101212_b0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens Pregnancy."},{"issue":"3","key":"10.1016\/j.preghy.2025.101212_b0215","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/HYPERTENSIONAHA.121.17311","article-title":"Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period","volume":"78","author":"Burwick","year":"2021","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.preghy.2025.101212_b0220","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2215\/CJN.13121211","article-title":"Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy","volume":"7","author":"Fakhouri","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7418","key":"10.1016\/j.preghy.2025.101212_b0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature11462","article-title":"Pregnancy imprints regulatory memory that sustains anergy to fetal antigen","volume":"490","author":"Rowe","year":"2012","journal-title":"Nature"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:39:36Z","timestamp":1762601976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778925000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":45,"alternative-id":["S2210778925000285"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101212","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy-related Thrombotic Microangiopathy has a spectrum of underlying causes","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101212"}}